Baseline MUGA scans for patients with early-stage breast cancer receiving adjuvant chemotherapy

被引：0
|
作者：
Jeyakumar, A. S.
Dipenta, J.
Snow, S. L.
Rayson, D.
Thompson, K.
Theriault, C.
Younis, T.
机构：
[1] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[2] Dalhousie Univ, Dartmouth, NS, Canada
[3] Capital Hlth, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6087
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant chemotherapy for early-stage breast cancer
    McArthur, Heather L.
    Hudis, Clifford A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 207 - +
  • [2] Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
    Michelle Shayne
    Jeffrey Crawford
    David C. Dale
    Eva Culakova
    Gary H. Lyman
    Breast Cancer Research and Treatment, 2006, 100 : 255 - 262
  • [3] Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
    Shayne, Michelle
    Crawford, Jeffrey
    Dale, David C.
    Culakova, Eva
    Lyman, Gary H.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (03) : 255 - 262
  • [4] Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast Cancer
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (10) : 1137 - +
  • [5] Optimizing adjuvant chemotherapy in early-stage breast cancer
    Perez, Edith
    Muss, Hyman B.
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1759 - 1767
  • [6] Real-world outcomes in patients receiving neo-adjuvant chemotherapy for early-stage breast cancer
    McDonald, Catherine
    Squires, Rebecca
    Gormley, Mark
    Langdon, Ryan
    Archer, Ann
    Ball, Jessica
    Gullick, Georgina
    Caws, Chloe
    Boardman, John
    Mohan, Vivek
    Bahl, Amit
    Jenkins, Jessica
    Comins, Charles
    Gibbs, Lara
    Braybrooke, Jeremy
    Robinson, Timothy
    CANCER RESEARCH, 2021, 81 (04)
  • [7] Factors associated with reduced dose intensity in patients receiving adjuvant chemotherapy for early-stage breast cancer (ESBC).
    Lyman, GH
    Wolff, DA
    Culakova, E
    Poniewierski, A
    Dale, DC
    Crawford, J
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S60 - S60
  • [8] A prospective risk model for neutropenic complications in early-stage breast cancer patients receiving adjuvant chemotherapy.
    Lyman, GH
    Kuderer, NM
    Shayne, M
    Dale, DC
    Wolff, D
    Culakova, E
    Poniewierski, MS
    Crawford, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S125 - S126
  • [9] Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?
    Bedard, Philippe L.
    Cardoso, Fatima
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (05) : 272 - 279
  • [10] Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
    Jansen, SJT
    Kievit, J
    Nooij, MA
    de Haes, JCJM
    Overpelt, IME
    van Slooten, H
    Maartense, E
    Stiggelbout, AM
    BRITISH JOURNAL OF CANCER, 2001, 84 (12) : 1577 - 1585
12345